MiR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1

Prostate

Volumn 74, Issue 16, 2014, Pages 1613-1621

  Sun, Qian ^a,b   Zhao, Xian ^b   Liu, Xin ^b   Wang, Yanli ^b   Huang, Jian ^b   Jiang, Bing ^a   Chen, Qin ^b,c   Yu, Jianxiu ^a,b  

^a School of Medicine   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Building 7 ^*  (China)

Author keywords

miR 146a; prostate cancer; Rac1; tumor metastasis

Indexed keywords

MICRORNA 146A; RAC1 PROTEIN; MICRORNA; MIRN146 MICRORNA, HUMAN; RAC1 PROTEIN, HUMAN; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ARTICLE; BINDING AFFINITY; CANCER INHIBITION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; MALE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICRORNAS; PROSTATIC NEOPLASMS; RAC1 GTP-BINDING PROTEIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84921728619     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22878     Document Type: Article

References (25)

1. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E,. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012; 62: 220-241.
2. Sturge J, Caley MP, Waxman J,. Bone metastasis in prostate cancer: Emerging therapeutic strategies. Nat Rev Clin Oncol 2011; 8: 357-368.
3. Maugeri-Sacca M, Coppola V, Bonci D, De Maria R,. MicroRNAs and prostate cancer: From preclinical research to translational oncology. Cancer J 2012; 18: 253-261.
4. Fang YX, Gao WQ,. Roles of microRNAs during prostatic tumorigenesis and tumor progression. Oncogene 2013.
5. Kim WT, Kim WJ,. MicroRNAs in prostate cancer. Prostate Int 2013; 1: 3-9.
6. Taganov KD, Boldin MP, Chang KJ, Baltimore D,. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006; 103: 12481-12486.
7. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA,. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol 2008; 180: 5689-5698.
8. Chen G, Umelo IA, Lv S, Teugels E, Fostier K, Kronenberger P, Dewaele A, Sadones J, Geers C, De Greve J,. miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS One 2013; 8: e60317.
9. Kogo R, Mimori K, Tanaka F, Komune S, Mori M,. Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res 2011; 17: 4277-4284.
10. Li Y, Vandenboom TG 2nd, Wang Z, Kong D, Ali S, Philip PA, Sarkar FH,. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res 2010; 70: 1486-1495.
11. Lin SL, Chiang A, Chang D, Ying SY,. Loss of mir-146a function in hormone-refractory prostate cancer. RNA 2008; 14: 417-424.
12. Yao Q, Cao Z, Tu C, Zhao Y, Liu H, Zhang S,. MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2. Cancer Lett 2013; 335: 219-224.
13. Bae VL, Jackson-Cook CK, Brothman AR, Maygarden SJ, Ware JL,. Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expression. Int J Cancer 1994; 58: 721-729.
14. Liu X, Chen Q, Yan J, Wang Y, Zhu C, Chen C, Zhao X, Xu M, Sun Q, Deng R, Zhang H, Qu Y, Huang J, Jiang B, Yu J,. MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumor cells. Cell Death Dis 2013; 4: e928.
15. Bae VL, Jackson-Cook CK, Maygarden SJ, Plymate SR, Chen J, Ware JL,. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line. Prostate 1998; 34: 275-282.
16. Liu X, Wang Y, Sun Q, Yan J, Huang J, Zhu S, Yu J,. Identification of microRNA transcriptome involved in human natural killer cell activation. Immunol Lett 2012; 143: 208-217.
17. Huang J, Yan J, Zhang J, Zhu S, Wang Y, Shi T, Zhu C, Chen C, Liu X, Cheng J, Mustelin T, Feng GS, Chen G, Yu J,. SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane. Nat Commun 2012; 3: 911.
18. Limame R, Wouters A, Pauwels B, Fransen E, Peeters M, Lardon F, De Wever O, Pauwels P,. Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS One 2012; 7: e46536.
19. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A,. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2005; 102: 19075-19080.
20. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM,. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008; 3: e2557.
21. Wang J, Shiozawa Y, Wang Y, Jung Y, Pienta KJ, Mehra R, Loberg R, Taichman RS,. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 2008; 283: 4283-4294.
22. Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H, Harbeck N, Schmitt M, Lengyel E,. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 2000; 19: 3013-3020.
23. Pan Y, Bi F, Liu N, Xue Y, Yao X, Zheng Y, Fan D,. Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun 2004; 315: 686-691.
24. Kamai T, Yamanishi T, Shirataki H, Takagi K, Asami H, Ito Y, Yoshida K,. Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res 2004; 10: 4799-4805.
25. Engers R, Ziegler S, Mueller M, Walter A, Willers R, Gabbert HE,. Prognostic relevance of increased Rac GTPase expression in prostate carcinomas. Endocr Relat Cancer 2007; 14: 245-256.